Back to today’s briefing

Story perspectives

AI Revolutionizes Prenatal Heart Defect Detection, Boosts Accuracy

2/1/2025

29 6

Summary

Story summary

A groundbreaking study unveiled at the Society for Maternal-Fetal Medicine meeting reveals that AI dramatically boosts the detection of congenital heart defects (CHDs) in prenatal ultrasounds. Spearheaded by Dr. Jennifer Lam-Rachlin, the research showcased enhanced accuracy and confidence among specialists, paving the way for improved neonatal health. Notably, BrightHeart's AI software gained FDA approval in November 2024.

1 of 1

Story summary

A groundbreaking study unveiled at the Society for Maternal-Fetal Medicine meeting reveals that AI dramatically boosts the detection of congenital heart defects (CHDs) in prenatal ultrasounds. Spearheaded by Dr. Jennifer Lam-Rachlin, the research showcased enhanced accuracy and confidence among specialists, paving the way for improved neonatal health. Notably, BrightHeart's AI software gained FDA approval in November 2024.